Question 1

What does The Medicines do?

Accepted Answer

The Medicines is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective

Question 2

In what sectors does The Medicines operate?

Accepted Answer

The Medicines operates in Biotechnology, Health Care, Pharmaceutical.

Question 3

How many companies has The Medicines acquired?

Accepted Answer

The Medicines has made 7 acquisitions between 2008-2014, with a total disclosed deal value of $756.0M.

Question 4

What companies are owned by The Medicines?

Accepted Answer

Companies acquired by The Medicines include Tenaxis Medical, Rempex Pharmaceuticals, ProFibrix, Incline Therapeutics, ApoA-I Milano, Targanta Therapeutics, Curacyte Discovery GmbH.

Question 5

What are The Medicines's major acquisitions?

Accepted Answer

The Medicines's largest acquisitions include Rempex Pharmaceuticals ($474.0M, 2013), ProFibrix ($240.0M, 2013), Targanta Therapeutics ($42.0M, 2009).

Question 6

What is The Medicines's largest acquisition?

Accepted Answer

The Medicines's largest disclosed acquisition is Rempex Pharmaceuticals for $474.0M (2013).

Question 7

What was The Medicines's first acquisition?

Accepted Answer

The Medicines's first recorded acquisition was Curacyte Discovery GmbH in 2008.

Question 8

What was The Medicines's most recent acquisition?

Accepted Answer

The Medicines's most recent acquisition is Tenaxis Medical, announced April 2014.

Question 9

What is the average deal size for The Medicines acquisitions?

Accepted Answer

The average disclosed deal size for The Medicines acquisitions is $252.0M.

Question 10

What is the median deal size for The Medicines acquisitions?

Accepted Answer

The median disclosed deal size for The Medicines acquisitions is $240.0M. The median is often lower than the average because a few very large deals pull the average up.

Question 11

How much has The Medicines spent on acquisitions?

Accepted Answer

The Medicines has spent at least $756.0M across its disclosed acquisitions (of 7 total deals; some prices are undisclosed).

Question 12

Which sector has The Medicines spent the most on?

Accepted Answer

The Medicines has committed the most disclosed capital to Biopharma companies — about $756.0M across its deals in that sector.

Question 13

What sectors does The Medicines usually acquire in?

Accepted Answer

The Medicines most frequently acquires companies in Biotechnology, Pharmaceutical, Biopharma.

Question 14

In which sector has The Medicines made the most acquisitions?

Accepted Answer

The Medicines has made the most acquisitions in the Biotechnology sector.

Question 15

In which year did The Medicines make the most acquisitions?

Accepted Answer

The Medicines made the most acquisitions in 2013, with 2 deals.

Datasets

Top Companies

Top Industries

Years (1990-2026)

The Medicines

Company Details

Funding & Financials

Web Traffic

Company Info

Acquisitions by The Medicines

Key People at The Medicines

Explore 200,000+ acquisitions — free

Recent News related to The Medicines

FAQs about The Medicines

People who checked this page also checked these